Mixed ET(A/B) and selective ET(A) receptor antagonists showed promising hemodynamic and symptomatic improvements in patients with heart failure. Randomized, clinical trials to investigate the effects of ET receptor antagonists on survival in patients with heart failure still need to be conducted. Also, the effects of selective ET(A) and mixed ET(A/B) receptor antagonists on the clinical outcome of patients with CHF will have to be assessed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0025-7125(02)00186-4 | DOI Listing |
Publication Analysis
Top Keywords
receptor antagonists
16
mixed eta/b
8
selective eta
8
patients heart
8
heart failure
8
will endothelin
4
receptor
4
endothelin receptor
4
antagonists
4
antagonists role
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!